 | Up a level |
Velayutham, Naveen Kumar and Thamaraikani, Tamilanban and Wahab, Shadma and Khalid, Mohammad and Gobinath, Ramachawolran and Abullais, Shahabe Saquib and Wong, Ling Shing and Mahendran, Sekar and Gan, Siew Hua and Ebenezer, Angel Jemima and Ravikumar, Mrinalini and Vetriselvan, Subramaniyan * and Nur Najihah, Izzati Mat Rani and Wu, Yuan Seng * and Jeyabalan, Srikanth (2024) Corrigendum: Stylopine: a potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy. Frontiers in Pharmacology, 15. ISSN 1663-9812
Kalaimani, Markandan and Revanthy, Sankaran and Tiong, Yong Wei and Humaira, Siddiqui * and Khalid, Mohammad and Malik, Sumira and Rustagi, Sarvesh (2023) A Review on the Progress in Chemo-Enzymatic Processes for CO2 Conversion and Upcycling. Catalysts, 13 (3). ISSN 2073-4344
Velayutham, Naveen Kumar and Thamaraikani, Tamilanban and Wahab, Shadma and Khalid, Mohammad and Gobinath, Ramachawolran and Abullais, Shahabe Saquib and Wong, Ling Shing and Mahendran, Sekar and Gan, Siew Hua and Ebenezer, Angel Jemima and Ravikumar, Mrinalini and Subramaniyan, Vetriselvan and Nur Najihah, Izzati Mat Rani and Wu, Yuan Seng * and Jeyabalan, Srikanth (2023) Stylopine: A potential natural metabolite to activate vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy. Frontiers in Pharmacology, 14. ISSN 1663-9812
